CEO share program

28 May 2025 14:05 CEST

Medistim ASA has transferred 10 000 shares to CEO Kari Krogstad's 100% owned
company K2 Consulting. This is according to the agreement entered between
Medistim ASA and the CEO under the same terms as described in the annual report.
The shares have a lock up period of 3 years and this qualifies for a 25%
discount. Average share price in the 14 days subscription period was NOK 173 per
share. The shares were therefore purchased at 129,78 per share. To finance the
purchase, Medistim has given the CEO a loan and when the lock in period has
ended, she is given a bonus equal to the loan amount. K2 Consulting AS has in
total 33.500 shares after the purchase. After these transactions Kari E.
Krogstad controls in total 80.583 Medistim shares. Medistim ASA has 83.117 own
shares after the transactions.

More information:
Access the news on Oslo Bors NewsWeb site